Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC.
Park JW, et al. Among authors: benz cc.
Clin Cancer Res. 2002 Apr;8(4):1172-81.
Clin Cancer Res. 2002.
PMID: 11948130